Bruce C Cozadd Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Bruce C Cozadd is Chairman & CEO of Jazz Pharmaceuticals plc. Currently has a direct ownership of 437,973 shares of JAZZ, which is worth approximately $46.8 Million. The most recent transaction as insider was on Dec 01, 2021, when has been sold 9,700 shares (Ordinary Shares) at a price of $46.83 per share, resulting in proceeds of $454,251. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 438K

0.87% 3M change

1.9% 12M change

Total Value Held $46.8 Million

BRUCE C COZADD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2021	BUY Exercise of conversion of derivative security	$454,251 $46.83 p/Share	9,700 Added 2.9%	325,299 Ordinary Shares
Nov 01 2021	SELL Open market or private sale	$882,700 $134.64 p/Share	6,556 Reduced 2.04%	315,536 Ordinary Shares
Nov 01 2021	BUY Exercise of conversion of derivative security	$454,251 $46.83 p/Share	9,700 Added 2.92%	322,092 Ordinary Shares
Oct 04 2021	SELL Open market or private sale	$856,882 $129.87 p/Share	6,598 Reduced 2.07%	312,392 Ordinary Shares
Oct 04 2021	BUY Exercise of conversion of derivative security	$454,251 $46.83 p/Share	9,700 Added 2.95%	318,990 Ordinary Shares
Sep 01 2021	SELL Open market or private sale	$65,790 $131.58 p/Share	500 Reduced 0.16%	309,290 Ordinary Shares
Aug 05 2021	BUY Exercise of conversion of derivative security	$124,193 $46.83 p/Share	2,652 Added 0.85%	309,790 Ordinary Shares
Aug 02 2021	SELL Open market or private sale	$297,483 $169.99 p/Share	1,750 Reduced 0.57%	307,138 Ordinary Shares
Jul 01 2021	SELL Open market or private sale	$1,960,269 $180.67 p/Share	10,850 Reduced 3.39%	308,888 Ordinary Shares
Jun 01 2021	SELL Open market or private sale	$313,373 $179.07 p/Share	1,750 Reduced 0.54%	319,738 Ordinary Shares
May 05 2021	SELL Open market or private sale	$85,000 $170.0 p/Share	500 Reduced 0.16%	321,341 Ordinary Shares
May 03 2021	SELL Open market or private sale	$246,360 $164.24 p/Share	1,500 Reduced 0.46%	321,841 Ordinary Shares
Apr 01 2021	SELL Open market or private sale	$247,440 $164.96 p/Share	1,500 Reduced 0.46%	323,341 Ordinary Shares
Mar 05 2021	SELL Payment of exercise price or tax liability	$3,544,761 $164.75 p/Share	21,516 Reduced 6.21%	324,841 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$1,632,000 $170.0 p/Share	9,600 Reduced 2.7%	346,357 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	37,925 Added 9.63%	355,957 Ordinary Shares
Feb 03 2021	SELL Open market or private sale	$40,000 $160.0 p/Share	250 Reduced 0.08%	318,032 Ordinary Shares
Feb 01 2021	SELL Open market or private sale	$195,187 $156.15 p/Share	1,250 Reduced 0.39%	318,282 Ordinary Shares
Jan 04 2021	SELL Open market or private sale	$1,287,979 $162.01 p/Share	7,950 Reduced 2.43%	319,532 Ordinary Shares
Dec 03 2020	SELL Open market or private sale	$37,500 $150.0 p/Share	250 Reduced 0.08%	327,482 Ordinary Shares
Dec 01 2020	SELL Open market or private sale	$140,580 $140.58 p/Share	1,000 Reduced 0.3%	327,732 Ordinary Shares
Nov 03 2020	SELL Open market or private sale	$385,000 $154.0 p/Share	2,500 Reduced 0.75%	328,680 Ordinary Shares
Nov 02 2020	SELL Open market or private sale	$145,130 $145.13 p/Share	1,000 Reduced 0.3%	331,180 Ordinary Shares
Oct 01 2020	SELL Open market or private sale	$638,730 $141.94 p/Share	4,500 Reduced 1.34%	332,180 Ordinary Shares

Also insider at

SLRN

ACELYRIN, Inc.

Director

BCC

Bruce C Cozadd

Chairman & CEO

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account